Company’s Liver Cancer Drug Candidate IP Portfolio strengthened Company provides operational...

Read More ...

NEW YORK, February 10, 2023 - Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial...

Read More ...

Company converts future royalty into 15% equity in multi-billion dollar potential product...

Read More ...